Connect with us


Gilead to test inhaled form of COVID-19 drug to widen its use – msnNOW

Gilead Sciences Inc. said it plans to start human trials of an inhaled version of its anti-Covid-19 drug remdesivir, a move that could significantly expand its use if successful.




© Bloomberg
Signage is displayed outside Gilead Sciences Inc. headquarters in Foster City, California, U.S., on Thursday, March 19, 2020. Gilead Sciences stock jumped as much as 7% on Thursday, rea…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Shake Shack manager accused of poisoning shakes sues NYPD officers, union for defamation – NBC News
Article feature image
Traders look for Bitcoin price daily close at $41K to confirm bullish reversal – Cointelegraph
Article feature image
Senate confirms progressive tech critic Lina Khan to become an FTC commissioner – CNBC